Catabasis Pharmaceuticals to Present at Oppenheimer’s 27th Annual Healthcare Conference
March 15 2017 - 8:00AM
Business Wire
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutical company, today announced that Jill C. Milne,
Ph.D., Chief Executive Officer, will present a corporate and
pipeline overview at Oppenheimer’s 27th Annual Healthcare
Conference on March 22, 2017 at 3:20pm ET at the Westin New York
Grand Central Hotel in New York City, NY.
A webcast of the presentation will be available in the Investors
section of the Company’s website, www.catabasis.com, and will be
archived for 30 days following the presentation.
About Catabasis
At Catabasis Pharmaceuticals, our mission is to bring hope and
life-changing therapies to patients and their families. Our SMART
(Safely Metabolized And Rationally Targeted) linker drug discovery
platform enables us to engineer molecules that simultaneously
modulate multiple targets in a disease. We are applying our SMART
linker platform to build an internal pipeline of product candidates
for rare diseases and plan to pursue partnerships to develop
additional product candidates. For more information on the
Company's drug discovery platform and pipeline of drug candidates,
please visit www.catabasis.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170315005034/en/
Corporate and Media
ContactCatabasis Pharmaceuticals, Inc.Andrea Matthews,
617-349-1971amatthews@catabasis.com
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Apr 2023 to Apr 2024